Teneliximab

From WikiProjectMed
Jump to navigation Jump to search
Teneliximab
Monoclonal antibody
TypeWhole antibody
SourceChimeric (mouse/human)
TargetCD40
Clinical data
ATC code
  • none
Identifiers
CAS Number
  • 299423-37-3 ☒N
ChemSpider
  • none
UNII
KEGG
 ☒NcheckY (what is this?)  (verify)

Teneliximab is a chimeric monoclonal antibody[1] binding to the immune stimulatory protein CD40.[2] As of 2009, it has not entered clinical trials.[2]

References

  1. ^ International Nonproprietary Names For Pharmaceutical Substances
  2. ^ a b Law CL, Grewal IS (2009). "Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges". Advances in Experimental Medicine and Biology. New York, N.Y.: Springer Science+Business Media. 647: 8–36. doi:10.1007/978-0-387-89520-8_2. ISBN 978-0-387-89520-8. PMID 19760064.